Nabriva Therapeutics plc Shareholders' Equity
Nabriva Therapeutics plc had Shareholders' Equity of -$16.32 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-10-19
- 2023-06-30: Stockholders' Equity Attributable to Parent -$16.32M.
- 2023-03-31: Stockholders' Equity Attributable to Parent -$4.36M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $3.29M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $25.62M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-06-30 | -$16.32M 10-Q · filed 2023-10-19 | |
| 2023-03-31 | -$4.36M 10-Q · filed 2023-10-19 | |
| 2022-12-31 | $3.29M 10-Q · filed 2023-10-19 | |
| 2022-09-30 | $25.62M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $34.60M 10-Q · filed 2023-10-19 | |
| 2022-03-31 | $44.63M 10-Q · filed 2023-10-19 | |
| 2021-12-31 | $53.35M 10-Q · filed 2023-10-19 | |
| 2021-09-30 | $63.29M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $69.20M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $54.99M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $33.13M 10-K · filed 2023-04-17 | |
| 2020-09-30 | $36.23M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $44.46M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $19.91M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $41.27M 10-K · filed 2023-04-17 | |
| 2019-09-30 | $39.22M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $43.41M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $60.11M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $68.63M 10-K · filed 2022-03-29 | |
| 2018-09-30 | $96.43M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $74.67M 10-Q · filed 2019-11-12 | $74.67M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $88.44M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $82.07M 10-K · filed 2021-03-11 | |
| 2017-09-30 | $103.14M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $49.55M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $62.72M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $77.26M 10-K · filed 2020-03-12 | |
| 2015-12-31 | $108.71M 10-K · filed 2019-03-12 | |
| 2014-12-31 | -$29.01M 10-K · filed 2018-03-16 | |
| 2013-12-31 | -$18.63M 10-K · filed 2017-03-24 |